Correction to: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2018), 10.1038/s41380-018-0256-5)

Maurizio Fava; Marlene P. Freeman; Martina Flynn; Heidi Judge; Bettina B. Hoeppner; Cristina Cusin; Dawn F. Ionescu; Sanjay J. Mathew; Lee C. Chang; Dan V. Iosifescu; James Murrough; Charles Debattista; Alan F. Schatzberg; Madhukar H. Trivedi; Manish K. Jha; Gerard Sanacora; Samuel T. Wilkinson; George I. Papakostas

doi:10.1038/s41380-018-0311-2

Correction to: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2018), 10.1038/s41380-018-0256-5)

Maurizio Fava, Marlene P. Freeman, Martina Flynn, Heidi Judge, Bettina B. Hoeppner, Cristina Cusin, Dawn F. Ionescu, Sanjay J. Mathew, Lee C. Chang, Dan V. Iosifescu, James Murrough, Charles Debattista, Alan F. Schatzberg, Madhukar H. Trivedi, Manish K. Jha, Gerard Sanacora, Samuel T. Wilkinson, George I. Papakostas

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Supplementary Figure 1 and Supplementary Tables 1–4 have been re-uploaded so as to reflect the versions supplied during proofs stage. The publisher apologizes for the error in versioning. The HTML version of the paper has been updated.

Original language	English (US)
Journal	Molecular psychiatry
DOIs	https://doi.org/10.1038/s41380-018-0311-2
State	Accepted/In press - Jan 1 2019

ASJC Scopus subject areas

Molecular Biology
Psychiatry and Mental health
Cellular and Molecular Neuroscience

Access to Document

10.1038/s41380-018-0311-2

Fingerprint

Dive into the research topics of 'Correction to: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2018), 10.1038/s41380-018-0256-5)'. Together they form a unique fingerprint.

Cite this

Fava, M., Freeman, M. P., Flynn, M., Judge, H., Hoeppner, B. B., Cusin, C., Ionescu, D. F., Mathew, S. J., Chang, L. C., Iosifescu, D. V., Murrough, J., Debattista, C., Schatzberg, A. F., Trivedi, M. H., Jha, M. K., Sanacora, G., Wilkinson, S. T., & Papakostas, G. I. (Accepted/In press). Correction to: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2018), 10.1038/s41380-018-0256-5). Molecular psychiatry. https://doi.org/10.1038/s41380-018-0311-2

Correction to: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2018), 10.1038/s41380-018-0256-5). / Fava, Maurizio; Freeman, Marlene P.; Flynn, Martina et al.
In: Molecular psychiatry, 01.01.2019.

Research output: Contribution to journal › Article › peer-review

Fava, M, Freeman, MP, Flynn, M, Judge, H, Hoeppner, BB, Cusin, C, Ionescu, DF, Mathew, SJ, Chang, LC, Iosifescu, DV, Murrough, J, Debattista, C, Schatzberg, AF, Trivedi, MH , Jha, MK, Sanacora, G, Wilkinson, ST & Papakostas, GI 2019, 'Correction to: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2018), 10.1038/s41380-018-0256-5)', Molecular psychiatry. https://doi.org/10.1038/s41380-018-0311-2

@article{6460fce9f8a543808e990d04e5f6f14e,

title = "Correction to: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2018), 10.1038/s41380-018-0256-5)",

abstract = "Supplementary Figure 1 and Supplementary Tables 1–4 have been re-uploaded so as to reflect the versions supplied during proofs stage. The publisher apologizes for the error in versioning. The HTML version of the paper has been updated.",

author = "Maurizio Fava and Freeman, {Marlene P.} and Martina Flynn and Heidi Judge and Hoeppner, {Bettina B.} and Cristina Cusin and Ionescu, {Dawn F.} and Mathew, {Sanjay J.} and Chang, {Lee C.} and Iosifescu, {Dan V.} and James Murrough and Charles Debattista and Schatzberg, {Alan F.} and Trivedi, {Madhukar H.} and Jha, {Manish K.} and Gerard Sanacora and Wilkinson, {Samuel T.} and Papakostas, {George I.}",

year = "2019",

month = jan,

day = "1",

doi = "10.1038/s41380-018-0311-2",

language = "English (US)",

journal = "Molecular psychiatry",

issn = "1359-4184",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Correction to

T2 - Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2018), 10.1038/s41380-018-0256-5)

AU - Fava, Maurizio

AU - Freeman, Marlene P.

AU - Flynn, Martina

AU - Judge, Heidi

AU - Hoeppner, Bettina B.

AU - Cusin, Cristina

AU - Ionescu, Dawn F.

AU - Mathew, Sanjay J.

AU - Chang, Lee C.

AU - Iosifescu, Dan V.

AU - Murrough, James

AU - Debattista, Charles

AU - Schatzberg, Alan F.

AU - Trivedi, Madhukar H.

AU - Jha, Manish K.

AU - Sanacora, Gerard

AU - Wilkinson, Samuel T.

AU - Papakostas, George I.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Supplementary Figure 1 and Supplementary Tables 1–4 have been re-uploaded so as to reflect the versions supplied during proofs stage. The publisher apologizes for the error in versioning. The HTML version of the paper has been updated.

AB - Supplementary Figure 1 and Supplementary Tables 1–4 have been re-uploaded so as to reflect the versions supplied during proofs stage. The publisher apologizes for the error in versioning. The HTML version of the paper has been updated.

UR - http://www.scopus.com/inward/record.url?scp=85059614865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059614865&partnerID=8YFLogxK

U2 - 10.1038/s41380-018-0311-2

DO - 10.1038/s41380-018-0311-2

M3 - Article

C2 - 30617276

SN - 1359-4184

JO - Molecular psychiatry

JF - Molecular psychiatry

ER -

Correction to: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (Molecular Psychiatry, (2018), 10.1038/s41380-018-0256-5)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this